The Canadian Competition Bureau cleared Aurora Cannabis Inc.'s C$1.1 billion acquisition of CanniMed Therapeutics Inc., a Canadian producer of medical cannabis.
Aurora Cannabis said it received a no-action letter from the Canadian regulator and the approval represents the final regulatory approval required for the deal.
The company will begin the take-up of CanniMed's shares once the 66.67% minimum tender condition is met. As of Feb. 28, 40% of CanniMed's outstanding shares had been tendered.
